Bacon (bleomycin, adriamycin, CCNU, oncovin and nitrogen mustard) in squamous lung cancer. Experience in fifty patients (Q39375010)

11 September 2017

BACON (bleomycin, adriamycin, CCNU, oncovin and nitrogen mustard) in squamous lung cancer. Experience in fifty patients (English)

2 references

11 September 2017

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A56980

9 April 2022

Bacon (bleomycin, adriamycin, CCNU, oncovin and nitrogen mustard) in squamous lung cancer. Experience in fifty patients (English)

1 reference

10.1002/1097-0142(197603)37:3<1237::AID-CNCR2820370302>3.0.CO;2-Z

https://api.crossref.org/works/10.1002/1097-0142(197603)37:3%3C1237::AID-CNCR2820370302%3E3.0.CO;2-Z

9 April 2022

1 reference

1 reference

10.1002/1097-0142(197603)37:3<1237::AID-CNCR2820370302>3.0.CO;2-Z

https://api.crossref.org/works/10.1002/1097-0142(197603)37:3%3C1237::AID-CNCR2820370302%3E3.0.CO;2-Z

9 April 2022

author name string

R. B. Livingston

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A56980

9 April 2022

W. H. Fee

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A56980

9 April 2022

L. H. Einhorn

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A56980

9 April 2022

M. A. Burgess

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A56980

9 April 2022

E. J. Freireich

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A56980

9 April 2022

J. A. Gottlieb

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A56980

9 April 2022

M. O. Farber

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A56980

9 April 2022

language of work or name

English

0 references

publication date

1 March 1976

1 reference

full work available at URL

11 September 2017

https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2F1097-0142(197603)37:3%3C1237::AID-CNCR2820370302%3E3.0.CO;2-Z

1 reference

10.1002/1097-0142(197603)37:3<1237::AID-CNCR2820370302>3.0.CO;2-Z

https://api.crossref.org/works/10.1002/1097-0142(197603)37:3%3C1237::AID-CNCR2820370302%3E3.0.CO;2-Z

https://onlinelibrary.wiley.com/doi/full/10.1002/1097-0142(197603)37:3%3C1237::AID-CNCR2820370302%3E3.0.CO;2-Z

9 April 2022

1 reference

10.1002/1097-0142(197603)37:3<1237::AID-CNCR2820370302>3.0.CO;2-Z

https://api.crossref.org/works/10.1002/1097-0142(197603)37:3%3C1237::AID-CNCR2820370302%3E3.0.CO;2-Z

9 April 2022

1 reference

11 September 2017

37

1 reference

11 September 2017

1237-1242

1 reference

11 September 2017

3

1 reference

Adriamycin. A new anticancer drug with significant clinical activity

11 September 2017

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%28197603%2937%3A3%3C1237%3A%3AAID-CNCR2820370302%3E3.0.CO%3B2-Z

Bronchogenic carcinoma. Factors in survival.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%28197603%2937%3A3%3C1237%3A%3AAID-CNCR2820370302%3E3.0.CO%3B2-Z

In vivo and in vitro studies on cell kinetics and synchronisation of human tumour cells: their significance in cytostatic tumour treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%28197603%2937%3A3%3C1237%3A%3AAID-CNCR2820370302%3E3.0.CO%3B2-Z

The survival of patients with inoperable lung cancer: a large-scale randomized study of radiation therapy versus placebo.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%28197603%2937%3A3%3C1237%3A%3AAID-CNCR2820370302%3E3.0.CO%3B2-Z

21 January 2018

2

31

1218

Barranco

1971

1 reference

10.1002/1097-0142(197603)37:3<1237::AID-CNCR2820370302>3.0.CO;2-Z

https://api.crossref.org/works/10.1002/1097-0142(197603)37:3%3C1237::AID-CNCR2820370302%3E3.0.CO;2-Z

Adriamycin chemotherapy--efficacy, safety, and pharmacologic basis of an intermittent single high-dosage schedule.

9 April 2022

3

33

19

Benjamin

1974

1 reference

10.1002/1097-0142(197603)37:3<1237::AID-CNCR2820370302>3.0.CO;2-Z

https://api.crossref.org/works/10.1002/1097-0142(197603)37:3%3C1237::AID-CNCR2820370302%3E3.0.CO;2-Z

9 April 2022

8

24

1918

Frei

1964

1 reference

10.1002/1097-0142(197603)37:3<1237::AID-CNCR2820370302>3.0.CO;2-Z

https://api.crossref.org/works/10.1002/1097-0142(197603)37:3%3C1237::AID-CNCR2820370302%3E3.0.CO;2-Z

Alkylating agents in bronchogenic carcinoma

9 April 2022

9

46

516

Green

1969

1 reference

10.1002/1097-0142(197603)37:3<1237::AID-CNCR2820370302>3.0.CO;2-Z

https://api.crossref.org/works/10.1002/1097-0142(197603)37:3%3C1237::AID-CNCR2820370302%3E3.0.CO;2-Z

Chemoimmunotherapy of Disseminated Malignant Melanoma with Dimethyl Triazeno Imidazole Carboxamide and Bacillus Calmette-Guérin

9 April 2022

COMB (cyclophosphamide, oncovin, methyl-CCNU, and bleomycin): a four-drug combination in solid tumors

10

0 references

14

36

327

Livingston

1975

1 reference

10.1002/1097-0142(197603)37:3<1237::AID-CNCR2820370302>3.0.CO;2-Z

https://api.crossref.org/works/10.1002/1097-0142(197603)37:3%3C1237::AID-CNCR2820370302%3E3.0.CO;2-Z

9 April 2022

Identifiers

10.1002/1097-0142(197603)37:3<1237::AID-CNCR2820370302>3.0.CO;2-Z

1 reference

11 September 2017

1 reference